Interview with Thomas Gardner, CEO of Biothech Company AtheraNova

Interviews

Interview with Thomas Gardner, CEO of Biothech Company AtheraNova

AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits


Details

Language: English

Year of Production: 2012

Length: 02:09

Country: United States